JP2013018787A5 - - Google Patents

Download PDF

Info

Publication number
JP2013018787A5
JP2013018787A5 JP2012227416A JP2012227416A JP2013018787A5 JP 2013018787 A5 JP2013018787 A5 JP 2013018787A5 JP 2012227416 A JP2012227416 A JP 2012227416A JP 2012227416 A JP2012227416 A JP 2012227416A JP 2013018787 A5 JP2013018787 A5 JP 2013018787A5
Authority
JP
Japan
Prior art keywords
administration
period
contraceptive
interruption period
woman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012227416A
Other languages
English (en)
Japanese (ja)
Other versions
JP6134491B2 (ja
JP2013018787A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013018787A publication Critical patent/JP2013018787A/ja
Publication of JP2013018787A5 publication Critical patent/JP2013018787A5/ja
Application granted granted Critical
Publication of JP6134491B2 publication Critical patent/JP6134491B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012227416A 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理 Expired - Lifetime JP6134491B2 (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US56644304P 2004-04-30 2004-04-30
US60/566,443 2004-04-30
US57502404P 2004-05-28 2004-05-28
US60/575,024 2004-05-28
US57719904P 2004-06-07 2004-06-07
US60/577,199 2004-06-07
US63838004P 2004-12-27 2004-12-27
US60/638,380 2004-12-27
US66006805P 2005-03-10 2005-03-10
US60/660,068 2005-03-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007509994A Division JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015126043A Division JP6153967B2 (ja) 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理

Publications (3)

Publication Number Publication Date
JP2013018787A JP2013018787A (ja) 2013-01-31
JP2013018787A5 true JP2013018787A5 (OSRAM) 2014-01-16
JP6134491B2 JP6134491B2 (ja) 2017-05-24

Family

ID=35056905

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007509994A Withdrawn JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理
JP2012227416A Expired - Lifetime JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理
JP2015126043A Expired - Lifetime JP6153967B2 (ja) 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理
JP2016241318A Withdrawn JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007509994A Withdrawn JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015126043A Expired - Lifetime JP6153967B2 (ja) 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理
JP2016241318A Withdrawn JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Country Status (29)

Country Link
US (3) US8163721B2 (OSRAM)
EP (1) EP1747001B1 (OSRAM)
JP (4) JP2007535519A (OSRAM)
KR (4) KR101812160B1 (OSRAM)
CN (1) CN103127156A (OSRAM)
AR (1) AR048722A1 (OSRAM)
AU (1) AU2005237255B2 (OSRAM)
BR (1) BRPI0510493A (OSRAM)
CA (1) CA2562296A1 (OSRAM)
CR (1) CR8709A (OSRAM)
DK (1) DK1747001T3 (OSRAM)
EA (2) EA031227B1 (OSRAM)
EC (1) ECSP066999A (OSRAM)
ES (1) ES2704999T3 (OSRAM)
HU (1) HUE041475T2 (OSRAM)
IL (1) IL178458A (OSRAM)
LT (1) LT1747001T (OSRAM)
MX (1) MXPA06012567A (OSRAM)
MY (1) MY151322A (OSRAM)
NO (1) NO341685B1 (OSRAM)
NZ (1) NZ586107A (OSRAM)
PA (1) PA8631801A1 (OSRAM)
PE (1) PE20060467A1 (OSRAM)
SG (2) SG152288A1 (OSRAM)
SI (1) SI1747001T1 (OSRAM)
SV (1) SV2006002100A (OSRAM)
TW (1) TWI374735B (OSRAM)
UY (1) UY28875A1 (OSRAM)
WO (1) WO2005105103A2 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20070088010A1 (en) * 2005-10-17 2007-04-19 Doris Huebler Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest
EP1977752A1 (de) * 2007-03-01 2008-10-08 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Zubereitung zur Verminderung der Endometriose
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
KR20110045065A (ko) * 2008-09-16 2011-05-03 플레이텍스 프로덕츠, 엘엘씨. 월경 억제, 피임 및 호르몬 대체 요법을 위한 약제 및 이를 투여하는 방법
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
ES2734510T3 (es) 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
US9198919B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
WO2010111488A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
HUE054551T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
NZ737948A (en) 2015-06-18 2023-03-31 Estetra Sprl Orodispersible dosage unit containing an estetrol component
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
KR102662025B1 (ko) 2015-06-18 2024-05-02 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
LT3313408T (lt) * 2015-06-23 2024-03-12 Laboratorios Leon Farma Sa Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
BR112019006227A2 (pt) 2016-09-30 2019-06-18 Myovant Sciences Gmbh métodos de tratamento de leiomioma uterino e endometriose
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US12138270B2 (en) 2021-09-07 2024-11-12 Millicent Pharma Limited Contraceptive regimen including reduced level of estrogen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244096A (en) 1988-04-22 1993-09-14 Stoner Fred L Preventive treatment kit against sexually transmitted disease
WO1993013801A1 (en) 1992-01-17 1993-07-22 The Procter & Gamble Company Treatment for atherosclerosis
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6451778B1 (en) * 1996-07-26 2002-09-17 Wyeth Oral contraceptive
NZ333750A (en) * 1996-07-26 2000-09-29 American Home Prod Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5842441A (en) 1996-08-26 1998-12-01 Pharmalett Denmark A/S Medicated and individualized treatment shampoo for dermatological disturbances of companion animals
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
RS50262B2 (sr) * 1999-08-31 2018-10-31 Bayer Pharma AG Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
CO5271709A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health
US20020193356A1 (en) * 2001-05-23 2002-12-19 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
US20030018018A1 (en) 2001-07-10 2003-01-23 Medical College Of Hampton Roads Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US8501720B2 (en) 2004-07-30 2013-08-06 Bayer Pharma AG Method for treatment of dysmenorrhea

Similar Documents

Publication Publication Date Title
JP2013018787A5 (OSRAM)
JP2015187157A5 (OSRAM)
JP2013529665A5 (OSRAM)
ES2561810T3 (es) Antagonistas de progesterona tales como CDB-4124 para reducir el dolor asociado a endometriosis y fibroides uterinos
JP2018193377A5 (OSRAM)
EA201400202A1 (ru) Применение эстетрола в качестве экстренного контрацептива
MX2022003132A (es) Composiciones de corticoesteroides administradas oralmente.
JP2013514984A5 (OSRAM)
HRP20191049T1 (hr) (11beta, 17beta)-17-hidroksi-11-[4-(metilsulfonil)fenil]-17-(pentalfuorometil)estra-4,9-dien-3-on za uporabu za liječenje bolesti
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
JP2016053040A5 (OSRAM)
PE20080273A1 (es) Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico
RU2011146058A (ru) Способ контрацепции, используемый по мере необходимости
JP2010180236A5 (OSRAM)
JP2013523349A5 (OSRAM)
JP2013517299A5 (OSRAM)
JP2013231087A5 (OSRAM)
HRP20240121T1 (hr) Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine
WO2011156812A3 (en) Intravaginal administration of misoprostol
JP2018527305A5 (OSRAM)
FI3973959T3 (fi) Kolestaattisen kutinan hoito seladelpaarilla
WO2014107730A3 (en) Use of fatty acid niacin conjugates for treating diseases
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
AR065816A1 (es) Regimen anticonceptivo oral
JP2013047269A5 (OSRAM)